May
01
2024
Newron’s schizophrenia add-on improves symptoms, charging up case for phase 3 test
Newron Pharmaceuticals’ add-on schizophrenia treatment improved both positive and negative symptoms as well as severity in patients with the disorder during a phase 2/3 study. The Italian biotech is …